Atacicept
VT-001-0020
Phase 2 small_molecule active
Quick answer
Atacicept for IgA Nephropathy (IgAN) is a Phase 2 program (small_molecule) at Vera Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vera Therapeutics
- Indication
- IgA Nephropathy (IgAN)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active